191 related articles for article (PubMed ID: 14706545)
1. Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.
Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Del Prete MS; Łukasiak J; Scalise G
Peptides; 2003 Sep; 24(9):1315-8. PubMed ID: 14706545
[TBL] [Abstract][Full Text] [Related]
2. Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii.
Rodríguez-Hernández MJ; Saugar J; Docobo-Pérez F; de la Torre BG; Pachón-Ibáñez ME; García-Curiel A; Fernández-Cuenca F; Andreu D; Rivas L; Pachón J
J Antimicrob Chemother; 2006 Jul; 58(1):95-100. PubMed ID: 16636085
[TBL] [Abstract][Full Text] [Related]
3. Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.
Giacometti A; Cirioni O; Del Prete MS; Barchiesi F; Paggi AM; Petrelli E; Scalise G
J Antimicrob Chemother; 2000 Nov; 46(5):807-10. PubMed ID: 11062203
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide, against multiresistant Acinetobacter baumannii strains.
Alarcón T; López-Hernández S; Andreu D; Saugar JM; Rivas L; López-Brea M
Rev Esp Quimioter; 2001 Jun; 14(2):184-90. PubMed ID: 11704773
[TBL] [Abstract][Full Text] [Related]
5. Activities of polymyxin B and cecropin A-,melittin peptide CA(1-8)M(1-18) against a multiresistant strain of Acinetobacter baumannii.
Saugar JM; Alarcón T; López-Hernández S; López-Brea M; Andreu D; Rivas L
Antimicrob Agents Chemother; 2002 Mar; 46(3):875-8. PubMed ID: 11850277
[TBL] [Abstract][Full Text] [Related]
6. Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.
Saugar JM; Rodríguez-Hernández MJ; de la Torre BG; Pachón-Ibañez ME; Fernández-Reyes M; Andreu D; Pachón J; Rivas L
Antimicrob Agents Chemother; 2006 Apr; 50(4):1251-6. PubMed ID: 16569836
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial efficacy of Cecropin A (1-7)- Melittin and Lactoferricin (17-30) against multi-drug resistant Salmonella Enteritidis.
Gourkhede DP; Bhoomika S; Pathak R; Yadav JP; Nishanth D; Vergis J; Malik SVS; Barbuddhe SB; Rawool DB
Microb Pathog; 2020 Oct; 147():104405. PubMed ID: 32707313
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumannii.
López-Rojas R; Docobo-Pérez F; Pachón-Ibáñez ME; de la Torre BG; Fernández-Reyes M; March C; Bengoechea JA; Andreu D; Rivas L; Pachón J
Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1391-8. PubMed ID: 21479973
[TBL] [Abstract][Full Text] [Related]
9. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
Akbari R; Hakemi-Vala M; Pashaie F; Bevalian P; Hashemi A; Pooshang Bagheri K
Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics.
Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Simona Del Prete M; Lukasiak J; Scalise G
Diagn Microbiol Infect Dis; 2004 Jul; 49(3):197-200. PubMed ID: 15246510
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
[TBL] [Abstract][Full Text] [Related]
12. Nucleation and growth of pores in 1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) / cholesterol bilayer by antimicrobial peptides melittin, its mutants and cecropin P1.
Lyu Y; Fitriyanti M; Narsimhan G
Colloids Surf B Biointerfaces; 2019 Jan; 173():121-127. PubMed ID: 30278360
[TBL] [Abstract][Full Text] [Related]
13. Structure-antibacterial, antitumor and hemolytic activity relationships of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.
Shin SY; Kang JH; Hahm KS
J Pept Res; 1999 Jan; 53(1):82-90. PubMed ID: 10195445
[TBL] [Abstract][Full Text] [Related]
14. Conformation of the cecropin-melittin hybrid, cecropin A(1-8)-melittin (1-18) antibacterial Peptide.
Tauro S; Coutinho E; Srivastava S
Protein Pept Lett; 2004 Apr; 11(2):115-24. PubMed ID: 15078199
[TBL] [Abstract][Full Text] [Related]
15. Retro and retroenantio analogs of cecropin-melittin hybrids.
Merrifield RB; Juvvadi P; Andreu D; Ubach J; Boman A; Boman HG
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3449-53. PubMed ID: 7724582
[TBL] [Abstract][Full Text] [Related]
16. Comparison of in vitro antibacterial activities of two cationic peptides CM15 and CM11 against five pathogenic bacteria: Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio cholerae, Acinetobacter baumannii, and Escherichia coli.
Moghaddam MM; Abolhassani F; Babavalian H; Mirnejad R; Azizi Barjini K; Amani J
Probiotics Antimicrob Proteins; 2012 Jun; 4(2):133-9. PubMed ID: 26781855
[TBL] [Abstract][Full Text] [Related]
17. Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.
Bardbari AM; Arabestani MR; Karami M; Keramat F; Aghazadeh H; Alikhani MY; Bagheri KP
Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):443-454. PubMed ID: 29353377
[TBL] [Abstract][Full Text] [Related]
18. Exploring Galleria mellonella larval model to evaluate antibacterial efficacy of Cecropin A (1-7)-Melittin against multi-drug resistant enteroaggregative Escherichia coli.
Vergis J; Malik SVS; Pathak R; Kumar M; Kurkure NV; Barbuddhe SB; Rawool DB
Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33512501
[TBL] [Abstract][Full Text] [Related]
19. Activities of synthetic peptides against human pathogenic bacteria.
Bogucka K; Królicka A; Kamysz W; Ossowski T; Lukasiak J; Lojkowska E
Pol J Microbiol; 2004; 53(1):41-4. PubMed ID: 15330266
[TBL] [Abstract][Full Text] [Related]
20. Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.
Andreu D; Ubach J; Boman A; Wåhlin B; Wade D; Merrifield RB; Boman HG
FEBS Lett; 1992 Jan; 296(2):190-4. PubMed ID: 1733777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
